Medicine and Dentistry
Phosphoprotein DARPP 32
100%
Brain
45%
Bipolar Disorder
27%
Single Nucleotide Polymorphism
27%
Cyclic Adenosine Monophosphate
27%
Messenger RNA
18%
Hippocampus
18%
Dopamine Agonist
18%
Dorsolateral Prefrontal Cortex
18%
Haplotype
18%
Genetic Variability
18%
Patient
18%
Phenotype
9%
Phosphoprotein
9%
Dopamine
9%
Brain Region
9%
Mood Disorder
9%
Major Depressive Episode
9%
Genetic Association
9%
Association
9%
Genotype
9%
Neuroscience
Phosphoprotein DARPP 32
100%
Dementia Praecox
63%
Bipolar Disorder
27%
Single-Nucleotide Polymorphism
27%
Dopaminergic
18%
Dorsolateral Prefrontal Cortex
18%
Haplotype
18%
Dopamine
9%
Phenotype
9%
Phosphoprotein
9%
Major Depressive Disorder
9%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphoprotein DARPP 32
100%
Schizophrenia
63%
Bipolar Disorder
27%
Messenger RNA
18%
Dopamine Receptor Stimulating Agent
18%
Dopamine
9%
Phosphoprotein
9%
Major Depression
9%
Psychology
Schizophrenia
63%
Bipolar Disorder
27%
Nucleotide
27%
Dorsolateral Prefrontal Cortex
18%
Hippocampus
9%
Human Brain
9%
Cognitive Performance
9%
Dopamine
9%
Major Depression
9%
Mood Disorder
9%
Cognitive Functioning
9%
Biochemistry, Genetics and Molecular Biology